Cargando…
Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
BACKGROUND: Circulating cell-free DNA (ccf-DNA) in plasma may contain both specific and non-specific of tumor markers. The concentration and integrity of ccf-DNA may be clinical useful for detecting and predicting cancer progression. METHODS: Plasma samples from 40 healthy controls and 73 patients w...
Autores principales: | Pu, Wang-Yang, Zhang, Rong, Xiao, Li, Wu, Yong-You, Gong, Wei, Lv, Xiao-Dong, Zhong, Feng-Yun, Zhuang, Zhi-Xiang, Bai, Xu-Ming, Li, Kai, Xing, Chun-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148873/ https://www.ncbi.nlm.nih.gov/pubmed/27938352 http://dx.doi.org/10.1186/s12885-016-2977-7 |
Ejemplares similares
-
Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
por: Yuan, Rong‐Xia, et al.
Publicado: (2022) -
Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022) -
The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
por: Sun, Pengcheng, et al.
Publicado: (2022) -
The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014) -
Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)